These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3100203)

  • 1. Myasthenia gravis. Laboratory and clinical analysis of 120 cases.
    Xu XH
    Chin Med J (Engl); 1986 Jul; 99(7):555-60. PubMed ID: 3100203
    [No Abstract]   [Full Text] [Related]  

  • 2. The laboratory diagnosis of mild myasthenia gravis.
    Kelly JJ; Daube JR; Lennon VA; Howard FM; Younge BR
    Ann Neurol; 1982 Sep; 12(3):238-42. PubMed ID: 7137958
    [No Abstract]   [Full Text] [Related]  

  • 3. Acetylcholine receptor antibodies in myasthenia gravis.
    Appel SH; Almon RR; Levy N
    N Engl J Med; 1975 Oct; 293(15):760-1. PubMed ID: 1160955
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acetylcholine receptor antibodies in myasthenia gravis].
    Yakirevich V; Snir E; Brener T; Borenstein N; Vidne BA
    Harefuah; 1983 Apr; 104(7):269-70. PubMed ID: 6618324
    [No Abstract]   [Full Text] [Related]  

  • 5. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Disorders of receptor function as a pathogenetic principle in myasthenia gravis].
    Toyka KV
    Internist (Berl); 1988 Jun; 29(6):414-9. PubMed ID: 3042682
    [No Abstract]   [Full Text] [Related]  

  • 7. Myasthenia gravis and autoantibodies.
    Nishitani H
    Jpn J Med; 1988 May; 27(2):228-9. PubMed ID: 3418994
    [No Abstract]   [Full Text] [Related]  

  • 8. Myasthenia gravis: a clinical review.
    Burke WJ
    Clin Exp Neurol; 1981; 17():1-14. PubMed ID: 7346191
    [No Abstract]   [Full Text] [Related]  

  • 9. [Myasthenia gravis--clinical and laboratory analysis of 120 cases].
    Xu XH
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Dec; 18(6):321-5. PubMed ID: 3836822
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical significance of immune complexes at the motor endplate in myasthenia gravis].
    Tsujihata M; Yoshimura T; Satoh A; Hazama R; Mori M
    Rinsho Shinkeigaku; 1983 Sep; 23(9):735-43. PubMed ID: 6673871
    [No Abstract]   [Full Text] [Related]  

  • 11. Acetylcholine release in myasthenia gravis: regulation at single end-plate level.
    Plomp JJ; Van Kempen GT; De Baets MB; Graus YM; Kuks JB; Molenaar PC
    Ann Neurol; 1995 May; 37(5):627-36. PubMed ID: 7755358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myasthenia gravis: biochemical and immunological aspects, status of research. (I)].
    Maufort-Nortier J
    Rev Med Brux; 1984 Nov; 5(9):579-88. PubMed ID: 6395256
    [No Abstract]   [Full Text] [Related]  

  • 13. Myasthenia gravis: a model disorder of acetylcholine receptors.
    Drachman DB
    Res Publ Assoc Res Nerv Ment Dis; 1987; 65():65-82. PubMed ID: 3330842
    [No Abstract]   [Full Text] [Related]  

  • 14. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
    Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A
    Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acetylcholine receptor antibodies in myasthenia gravis. Measurement of plasma concentration by immunoprecipitation].
    Gammeltoft S; Somnier FE
    Ugeskr Laeger; 1984 Jan; 146(5):352-5. PubMed ID: 6372187
    [No Abstract]   [Full Text] [Related]  

  • 16. Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset.
    Vincent A; Newsom-Davis J
    Clin Exp Immunol; 1982 Aug; 49(2):266-72. PubMed ID: 7127905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton magnetic resonance spectroscopy of the intrinsic tongue muscles in patients with myasthenia gravis with different autoantibodies.
    Lavrnic D; Dakovic M; Peric S; Rakocevic-Stojanovic V; Basta I; Marjanovic I; Stosic-Opincal T; Lavrnic S
    J Neurol Sci; 2011 Mar; 302(1-2):25-8. PubMed ID: 21236447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-MuSK antibodies: correlation with myasthenia gravis severity.
    Bartoccioni E; Scuderi F; Minicuci GM; Marino M; Ciaraffa F; Evoli A
    Neurology; 2006 Aug; 67(3):505-7. PubMed ID: 16894117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vocal cord paralysis in myasthenia gravis with anti-MuSK antibodies.
    Hara K; Mashima T; Matsuda A; Tanaka K; Tomita M; Shiraishi H; Motomura M; Nishizawa M
    Neurology; 2007 Feb; 68(8):621-2. PubMed ID: 17310039
    [No Abstract]   [Full Text] [Related]  

  • 20. [Myasthenia gravis syndrome following administration of d-penicillamine (author's transl)].
    Rousseau JJ; Dieudonne LG
    Acta Neurol Belg; 1980; 80(3):165-73. PubMed ID: 7457085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.